Murar Mashaƙo 2019
Murar Mashaƙo wata cuta ce mai yaduwa ta coronavirus SARS-CoV-2. An gano cutar ta farko da aka sani a Wuhan, China, a cikin Disamba 2019.[1] Yawancin masana kimiyya sun yi imanin cewa kwayar cutar ta SARS-CoV-2 ta shiga cikin al'ummomin mutane ta hanyar zoonosis na dabi'a, mai kama da barkewar SARS-CoV-1 da MERS-CoV, kuma daidai da sauran cututtukan cututtuka a tarihin ɗan adam.[2][3] Abubuwan zamantakewa da muhalli da suka haɗa da sauyin yanayi, lalata yanayin yanayin halitta da cinikin namun daji sun ƙaru da yuwuwar yaɗuwar zoonotic.[4][5][6][7] Cutar ta bazu cikin sauri a duk duniya, wanda ya haifar da cutar ta COVID-19.
Alamomin COVID-19 suna canzawa amma galibi sun haɗa da zazzabi, [8] gajiya, tari, wahalar numfashi, rasa wari, da rasa ɗanɗano.[9][10][11] Alamun na iya farawa daga kwana ɗaya zuwa sha huɗu bayan kamuwa da cutar. Aƙalla kashi ɗaya bisa uku na mutanen da suka kamu da cutar ba sa samun alamun bayyanar cu tuttuka.[12][13] Daga cikin wadanda suka kamu da alamun bayyanar da za a iya rarraba su a matsa8yin marasa lafiya, yawancin (81%) suna tasowa masu laushi zuwa matsakaici (har zuwa ciwon huhu), yayin da 14% ke haifar da cututtuka masu tsanani (dyspnea, hypoxia, ko fiye da kashi 50 cikin 100 na huhu a kan hoto). ), kuma 5% suna haifar da alamomi masu mahimmanci (rashin numfashi, girgiza, ko rashin aiki mai yawa).[14] Tsofaffi suna cikin haɗari mafi girma na kamuwa da waɗannan cututtuka masu tsanani. Wasu rikice-rikice suna haifar da mutuwa. Wasu mutane suna ci gaba da samun sakamako iri-iri (dogon COVID) na tsawon watanni ko shekaru bayan kamuwa da cuta, kuma an ga lalacewar gabobin.[15] Ana ci gaba da nazarin shekaru da yawa don ƙara yin bincike game da illolin da cutar ke daɗewa.[16]
Manazarta
[gyara sashe | gyara masomin]- ↑ Page J, Hinshaw D, McKay B (26 February 2021). "In Hunt for Covid-19 Origin, Patient Zero Points to Second Wuhan Market – The man with the first confirmed infection of the new coronavirus told the WHO team that his parents had shopped there". The Wall Street Journal. Retrieved 27 February 2021.
- ↑ Jiang X, Wang R (25 August 2022). "Wildlife trade is likely the source of SARS-CoV-2". Science. 377 (6609): 925–926. Bibcode:2022Sci...377..925J. doi:10.1126/science.add8384. PMID 36007033. S2CID 251843410. Retrieved 20 November 2022.
- ↑ Pekar J (26 July 2022). "The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2". Science. 377 (6609): 960–966. Bibcode:2022Sci...377..960P. doi:10.1126/science.abp8337. PMC 9348752. PMID 35881005.
- ↑ Health, Wellbeing, and the Changing Structure of Communities. In: Climate Change 2022: Impacts, Adaptation and Vulnerability. Contribution of Working Group II to the Sixth Assessment Report of the Intergovernmental Panel on Climate Change (PDF). IPCC. 2022. pp. 1067–1070. Retrieved 14 March 2023.
- ↑ "Climate change may have driven the emergence of SARS-CoV-2". University of Cambridge. Science of the Total Environment. 5 February 2021. Retrieved 14 March 2023.
- ↑ "Climate change the culprit in the COVID-19 pandemic". European Commission. Retrieved 24 March 2023.
- ↑ Terrestrial and Freshwater Ecosystems and Their Services. In: Climate Change 2022: Impacts, Adaptation and Vulnerability. Contribution of Working Group II to the Sixth Assessment Report of the Intergovernmental Panel on Climate Change (PDF). IPCC. 2022. pp. 233–235. Retrieved 14 March 2023.
- ↑ Islam MA (April 2021). "Prevalence and characteristics of fever in adult and paediatric patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of 17515 patients". PLOS ONE. 16 (4): e0249788. Bibcode:2021PLoSO..1649788I. doi:10.1371/journal.pone.0249788. PMC 8023501. PMID 33822812.
- ↑ Saniasiaya J, Islam MA (November 2020). "Prevalence and Characteristics of Taste Disorders in Cases of COVID-19: A Meta-analysis of 29,349 Patients" (PDF). Otolaryngology–Head and Neck Surgery. 165 (1): 33–42. doi:10.1177/0194599820981018. PMID 33320033. S2CID 229174644.
- ↑ Agyeman AA, Chin KL, Landersdorfer CB, Liew D, Ofori-Asenso R (August 2020). "Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis". Mayo Clin. Proc. 95 (8): 1621–1631. doi:10.1016/j.mayocp.2020.05.030. PMC 7275152. PMID 32753137.
- ↑ Saniasiaya J, Islam MA (April 2021). "Prevalence of Olfactory Dysfunction in Coronavirus Disease 2019 (COVID-19): A Meta-analysis of 27,492 Patients". The Laryngoscope. 131 (4): 865–878. doi:10.1002/lary.29286. ISSN 0023-852X. PMC 7753439. PMID 33219539.
- ↑ Oran DP, Topol EJ (January 2021). "The Proportion of SARS-CoV-2 Infections That Are Asymptomatic: A Systematic Review". Annals of Internal Medicine. 174 (5): M20-6976. doi:10.7326/M20-6976. PMC 7839426. PMID 33481642.
- ↑ Wang B, Andraweera P, Elliott S, Mohammed H, Lassi Z, Twigger A, et al. (March 2023). "Asymptomatic SARS-CoV-2 Infection by Age: A Global Systematic Review and Meta-analysis". The Pediatric Infectious Disease Journal. 42 (3): 232–239. doi:10.1097/INF.0000000000003791. PMC 9935239. PMID 36730054. Retrieved 15 November 2023.
- ↑ Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19)". U.S. Centers for Disease Control and Prevention (CDC). 6 April 2020. Archived from the original on 2 March 2020. Retrieved 19 April 2020.
- ↑ Davis HE, McCorkell L, Vogel JM, Topol EJ (March 2023). "Long COVID: major findings, mechanisms and recommendations". Nature Reviews. Microbiology. 21 (3): 133–146. doi:10.1038/s41579-022-00846-2. PMC 9839201. PMID 36639608.
- ↑ CDC (11 February 2020). "Post-COVID Conditions". U.S. Centers for Disease Control and Prevention (CDC). Retrieved 12 July 2021.